이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cutera 관리

관리 기준 확인 0/4

Cutera's CEO는 Taylor Harris, Aug2023 에 임명되었습니다 의 임기는 1년 미만입니다. 총 연간 보상은 $ 7.69M, 3.5% 로 구성됩니다. 3.5% 급여 및 96.5% 보너스(회사 주식 및 옵션 포함). 는 $ 48.90K 가치에 해당하는 회사 주식의 0.15% 직접 소유합니다. 48.90K. 경영진과 이사회의 평균 재임 기간은 각각 1 년과 1.1 년입니다.

주요 정보

Taylor Harris

최고 경영자

US$7.7m

총 보상

CEO 급여 비율	3.5%
CEO 임기	1.1yrs
CEO 소유권	0.4%
경영진 평균 재임 기간	1.1yrs
이사회 평균 재임 기간	1.3yrs

최근 관리 업데이트

Recent updates

Cutera, Inc. (NASDAQ:CUTR) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough

Aug 20

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Jun 22

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Mar 14

Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

Aug 11

An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Apr 19

Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 01

Cutera: The 'AviClear' Sign To Get Bullish

Jun 22

Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt

May 27

Returns On Capital Signal Tricky Times Ahead For Cutera (NASDAQ:CUTR)

Apr 22

Cutera: Gains Aren't Surprising After Acne Laser Therapy Cleared

Mar 31

CEO 보상 분석

Taylor Harris 의 보수는 Cutera 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	-US$149m
Mar 31 2024	n/a	n/a	-US$158m
Dec 31 2023	US$8m	US$271k	-US$163m

보상 대 시장: Taylor 의 총 보상 ($USD 7.69M )은 US 시장( $USD 683.56K ).

보상과 수익: Taylor 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Taylor Harris (48 yo)

1.1yrs

테뉴어

US$7,685,535

보상

Mr. Taylor C. Harris serves as Director of Omada Health, Inc. since February 2022. He serves as Advisor at Lauxera Capital Partners. Mr. Harris has been an Independent Director at HealthCor Catalio Acquisi...

리더십 팀

이름	위치	테뉴어	보상	소유권
Taylor Harris	President	1.1yrs	US$7.69m	0.38% $ 59.3k
Stuart Drummond	Chief Financial Officer	1.3yrs	US$777.83k	0.088% $ 13.7k
Jeffrey Jones	Chief Operating Officer	1.1yrs	US$541.00k	데이터 없음
Michael Karavitis	Executive VP & Chief Technology Officer	7.1yrs	US$1.20m	0.026% $ 4.0k
Stephana Patton	Chief Legal Officer	less than a year	US$347.73k	데이터 없음
Sheila Hopkins	Consultant	less than a year	US$1.82m	0.19% $ 30.2k
Charles Thier	Chief Information Officer	4.9yrs	US$1.86m	데이터 없음
Greg Barker	Vice President of FP&A and Investor Relations	no data	데이터 없음	데이터 없음
Steve Kreider	Senior Vice President of Global Marketing	2.7yrs	데이터 없음	데이터 없음
Brent Hauser	President of International	less than a year	데이터 없음	데이터 없음

1.1yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: CUTR 의 관리팀은 경험 (평균 재직 기간 1 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Taylor Harris	President	1.3yrs	US$7.69m	0.38% $ 59.3k
Jeryl Hilleman	Director	less than a year	데이터 없음	데이터 없음
Kevin Cameron	Independent Chairman	1.3yrs	US$285.40k	데이터 없음
Keith Sullivan	Independent Director	1.3yrs	US$220.05k	0.020% $ 3.0k
Nicholas Lewin	Independent Director	1.3yrs	US$268.79k	데이터 없음

1.3yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 이사회: CUTR 의 이사회는 경험(평균 재직 기간 1.1 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Cutera 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

High number of new and inexperienced directors

High number of new and inexperienced directors

Cutera, Inc., Annual General Meeting, Jul 15, 2024

High number of new and inexperienced directors

Cutera, Inc. Announces Resignation of Juliane Park from the Board of Directors, Effective as of December 1, 2023

Janet Widmann Resigns from the Board of Directors of Cutera, Inc. Effective November 1, 2023

Recent updates

Cutera, Inc. (NASDAQ:CUTR) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Cutera, Inc. Revises Revenue Guidance for the Year 2024

High number of new and inexperienced directors

Cutera, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Cutera, Inc.(NasdaqGS:CUTR) dropped from Russell 3000 Index

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Price target decreased by 17% to US$6.33

High number of new and inexperienced directors

Cutera, Inc., Annual General Meeting, Jul 15, 2024

Cutera, Inc. Reiterates Earnings Guidance for 2024

Cutera, Inc. to Report Q1, 2024 Results on May 09, 2024

Cutera, Inc. Announces North America Launch of xeo+

Cutera, Inc. Provides Revenue Guidance for the Full Year 2024

Cutera, Inc. announced delayed annual 10-K filing

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Consensus EPS estimates fall by 33%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Cutera, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Price target decreased by 59% to US$7.67

High number of new and inexperienced directors

Cutera, Inc. Revises Revenue Guidance for the Full Year 2023

Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q

Cutera, Inc. announced delayed 10-Q filing

Cutera, Inc. Announces Resignation of Juliane Park from the Board of Directors, Effective as of December 1, 2023

Cutera, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Janet Widmann Resigns from the Board of Directors of Cutera, Inc. Effective November 1, 2023

New minor risk - Market cap size

Cutera, Inc. Appoints Brent Hauser as President, International

Cutera, Inc. Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO

President recently bought US$297k worth of stock

Cutera, Inc. Appoints Jeffrey Jones as Chief Operating Officer, Effective August 28, 2023

Consensus revenue estimates fall by 14%

Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

New major risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 8.9% to US$23.00

Cutera, Inc. Provides Revenue Guidance for the Full Year 2023

Cutera, Inc. Appoints Talyor C. Harris as President, Effective August 7, 2023

Cutera, Inc. Announces CEO Changes, Effective August 7, 2023

Cutera, Inc. to Report Q2, 2023 Results on Aug 08, 2023

the Gross Law Firm Notifies Shareholders of Cutera, Inc. of A Class Action Lawsuit and A Lead Plaintiff Deadline of July 24, 2023

Cutera, Inc. Announces A New U.S. Food and Drug Administration Clearance of AviClear as A Long-Term Treatment for Mild to Severe Inflammatory Acne Vulgaris

Cutera, Inc. Announces Resignation of J. Daniel Plants as Director

Independent Director notifies of intention to sell stock

Cutera, Inc. Announces Resignation of Joseph E. Whitters from the Board of Directors

Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Cutera, Inc

Less than half of directors are independent

Cutera, Inc. Announces Board Changes

Cutera, Inc. Appoints Stuart Drummond as Interim Chief Financial Officer

Voce Capital and David Mowry Terminate Proxy Solicitation

Cutera, Inc. Announces Chief Financial Officer Changes

First quarter 2023 earnings: EPS and revenues miss analyst expectations

An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 57%

Now 21% undervalued after recent price drop

Full year 2022 earnings: EPS misses analyst expectations

Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet?

Price target decreased to US$61.20

Cutera, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Cutera, Inc. Announces AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch

Third quarter 2022 earnings released: US$0.62 loss per share (vs US$0.077 loss in 3Q 2021)

Cutera, Inc. Reiterates Revenue Guidance for the Full Year of 2022

Cutera, Inc. Announces Committee Appointments

Cutera, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Would Cutera (NASDAQ:CUTR) Be Better Off With Less Debt?

Cutera, Inc. Announces Resignation of Katherine S. Zanotti from the Board

Cutera: Shares Very Attractively Priced, Top-Line Hedged From CMS